Dulaglutide vs Lixisenatide

Dulaglutide (brand name Trulicity) and lixisenatide (brand names Adlyxin and Soliqua) are both GLP-1 receptor agonists, a type of medication that helps manage blood sugar. Dulaglutide is approved to treat type 2 diabetes and reduce cardiovascular risk, while lixisenatide is approved only for type 2 diabetes. Dulaglutide is given as a once-weekly injection, whereas lixisenatide is taken as a once-daily injection.

AI summary of the sources below.